Toronto, Ontario. October 27, 2023 – LifeLabs, a leading provider of laboratory diagnostic services, is thrilled to introduce our latest offering: self-collection Hormone Health kits. This exciting addition to our wellness assessment toolkit is set to enhance hormone testing for both healthcare providers and their patients in Canada. Kits are available across the country, excluding British Columbia. Hormone Health kits will be made available in B.C. beginning in early 2024.
Hormone Health kits enable collections for saliva hormone testing, a high-quality tool for patient assessment to uncover underlying functional hormone excesses, deficiencies, or imbalances. Interactions between cortisol, DHEAS, estradiol, progesterone, and testosterone, along with melatonin levels, are fundamental to health—which is why LifeLabs is providing a variety of options for testing including assessment of both individual hormones and panels. A single collection kit enables a flexible option for both patients and practitioners when ordering. The method is reliable, non-invasive, and convenient.
LifeLabs collection kits enable patients to conveniently collect samples in the comfort of their homes and send them to LifeLabs for testing. At-home sample collection offers a proactive, private, and flexible service channel, allowing Canadians to make informed decisions for better health outcomes.
“We’re thrilled to introduce Hormone Health kits for healthcare providers and their patients,” says Lawrence Mahan, Senior Vice President of Business and Consumer Markets at LifeLabs. “We believe that better health outcomes begin with informed decisions and these kits will help achieve that goal.”
One of the key highlights of this launch is LifeLabs’ proud partnership with a Canadian company, Keel Lab Services (part of Keel Digital), which ensures that all hormone health testing remains within the borders of Canada, supporting the country’s healthcare ecosystem.
“Keel Lab Services is proud to partner with LifeLabs and its launch of Hormone Health kits,” says Daniel Libertucci, Chief Scientific Officer at Keel Laboratory Services. “Together we can improve patient outcomes by providing the analytical data critical to forming pathways towards better health.”
Additional information about the kits is available on rmalab.com.
About LifeLabs
LifeLabs is Canada’s leading provider of laboratory diagnostic information and digital health connectivity systems, enabling patients and healthcare practitioners to diagnose, treat, monitor, and prevent disease. We support 20 million patient visits annually and conduct over 100 million laboratory tests through leading edge technologies and our 6,500 talented and dedicated employees. We are a committed innovator in supporting Canadians to live healthier lives, operating Canada’s first commercial genetics lab, and the country’s largest online patient portal, with more than 5 million Canadians receiving their results online. LifeLabs has been named one of Canada’s Best Employers (2021, 2022 and 2023) and Best Employers for Diversity (2022 and 2023) by Forbes and recognized for having an award-winning Mental Health Program from Benefits Canada. LifeLabs is 100% Canadian owned by OMERS Infrastructure, the infrastructure investment manager of one of Canada’s largest defined benefit pension plans. Learn more at lifelabs.com.
Media Contact: LifeLabs Media Team | Media@LifeLabs.com
About Keel Lab Services
Keel Lab Services is a proudly Canadian-owned and operated Ontario licensed and accredited laboratory. Our mission is to provide better patient outcomes by offering a highly specialized test menu while utilizing the latest in laboratory technology. Continued commitment to the development of non-invasive collection methods allows Keel Lab Services to offer purpose-driven testing solutions that provide the highest degree of excellence while always remaining focused on positive patient impact.